Cost-Effectiveness of Palliative Team Care For Patients Nearing End-Of-Life Society for Medical Decision Making 36 st Annual Meeting – Miami, Florida October.

Slides:



Advertisements
Similar presentations
AHA Annual Meeting AIM Panel April 30, 2013 Laura Mavity, MD, Clinical DirectorKatie Hartley, BSN, CHPN, Administrative Director Centers of Care Advanced.
Advertisements

1 Palliative Care and Shared Decision-Making HOW TO BECOME AN INFORMED HEALTHCARE DECISION MAKER.
Introduction to Pharmacoeconomics
Oncology and Palliative Care: Promoting the Comfort and Cure Model Parag Bharadwaj, MD FAAHPM.
Inpatient Palliative Care: What is it and Why it’s Important Lyra Sihra MD Associate Medical Director Gentiva Hospice.
University of Minnesota Medical Technology Evaluation and Market Research Course: MILI/PUBH 6589 Spring Semester, 2012 Stephen T. Parente, Ph.D. Carlson.
Cancer Care Delivery Reform: Role of Early Palliative Care and Communication about EOL Care Jennifer Temel, MD Massachusetts General Hospital March
Integrated Care for Patients With Late-Stage Chronic Illness Advanced Illness Management (AIM) Medical Foundations & Groups Home-Based Services Hospitals.
Return of the House Call A Breakfast Forum Housecall Providers June 4, 2014.
Middle Atlantic Actuarial Club September 17, 2009 Baltimore, MD Shannon Brownlee, MS Senior Research Fellow, New America Foundation Overtreated: Why Too.
The role of economic modelling – a brief introduction Francis Ruiz NICE International © NICE 2014.
Economic Analysis and Management Todd Wagner, PhD.
Recommendations for Conducting Cost Effectiveness: Elements of the Reference Case Ciaran S. Phibbs, Ph.D. February 25, 2009.
EXPECTED OUTCOMES The study will provide information on the impact of tobacco use on health from epidemiological, social and economic perspectives in relation.
Costs.
Palliative Care Cost : A look at the evidence
Program Development for Safety Net Institutions Catherine Deamant, MD Director, Palliative Care Services Cook County Health and Hospitals System Coleman.
Nancy D. Zionts Chief Operating Officer Chief Program Officer Jewish Healthcare Foundation © 2013 JHF & PRHI.
Homelessness and palliative care Michael Bramwell August 2014.
Economic Evaluations, Briefly… CHSC 433 Module 6/Chapter 13 UIC School of Public Health L. Michele Issel, PhD, R N.
End-of-Life Care in the Department of Veterans Affairs Jon Fuller, MD James Hallenbeck, MD James Breckenridge, PhD VA Palo Alto HCS.
Indianapolis Discovery Network for Dementia Forecasting the Future Impact of Early Detection and Management Program for Alzheimer.
Cost-Effectiveness Problem l You have a $1.5 billion budget to spend on any combination of these programs:
Value of Money in Cancer - IMRT as a case study
These slides were released by the speaker for internal use by Novartis.
Reduction Of Hospital Readmissions Hany Salama, MD Diplomat ABIM IM Hospice and Palliative Care Sleep Medicine.
PHAR 310: Pharmacoeconomics
Community Oncology Conference Thursday April 23 rd, 2015.
Evidence Evaluation & Methods Workgroup: Developing a Decision Analysis Model Lisa A. Prosser, PhD, MS September 23, 2011.
What cost evidence supports the use of technologies in home and community based caregiving of older adults? Presented by Brooke Harrow, PhD University.
SCHEN SCC-CSI MUSC Walter Limehouse MD MA MUSC Emergency Medicine.
Hospice Palliative Care Report to Central LHIN Board May 31, 2011 Dr. Nancy Merrow Chair, HPC Network for CLHIN.
End-of-Life Care in the Department of Veterans Affairs Jon Fuller, MD James Hallenbeck, MD James Breckenridge, PhD VA Palo Alto HCS.
BACKGROUND Cost-effectiveness of Psychotherapy for Cluster C Personality Disorders and the Value of Information and Implementation Djøra I. Soeteman 1,2,
Transitioning to Palliative Care: Starting the Conversation Dr. José Pereira Head Division of Palliative Care, University of Ottawa Medical Chief, Palliative.
Chang Gung University Lai-Chu See, Ph.D. Professor Department of Public Health, College of Medicine, Chang Gung University, Taiwan
Home Based Palliative Care Richard D. Brumley, MD Gretchen Phillips, MSW Kaiser Permanente Downey, CA Practice Change Fellows January 24, 2008.
Evolution & Maturation of the Practice of Hospice and Palliative Medicine Charles F. von Gunten, MD, PhD May 16, 2013 Vice President, Medical Affairs Hospice.
Impact of Restrictive State Policies on Utilization and Expenditures in the Medicaid Program Roberto Vargas, MD, MPH 1,2 Carole Gresenz, PhD 2 Jessie Riposo,
انواع ارزيابي های اقتصادي سيدرضا مجدزاده مرکز تحقيقات بهره برداری از دانش سلامت و دانشکده بهداشت دانشگاه علوم پزشکي و خدمات بهداشتي درماني تهران.
Will This Admission Help? Leonard Hock, D.O., CMD Covenant Hospice.
AcademyHealth 2007 Gender Differences in Healthcare Utilization at the End-of Life Andrea Kronman, MD MSc Boston University BIRCWH Faculty Scholar Women’s.
Barb Supanich, RSM, MD, FAAHPM Holy Cross IP Palliative Care Team November 11, 2010.
ERS Cost of Foodborne Illness Data Product Sandra Hoffmann (ERS) Bryan Maculloch (FSIS)
Economic evaluation of psychotherapy for personality disorders: burden of disease and cost-effectiveness Djøra Soeteman Viersprong Institute for Studies.
RESCUE: Assessing Health and Economic Outcomes William C. Black, M.D. Dartmouth-Hitchcock Medical Center.
Specialised Geriatric Services Heather Gilley Sharon Straus.
Pam Ehrbar Program Manager, Honoring Choices ® Pacific Northwest.
Looking at Frailty Through a New Lens John Strandmark, M.D. ©AAHCM.
Copyright © 2011 Wolters Kluwer Health | Lippincott Williams & Wilkins Chapter 8 Healthcare Delivery Systems.
COST ACCOUNTING WORKGROUP (members=health economists, health policy and clinician researchers, EOL Care Project PI’s) Stephen F. Seninger, Ph.D. Workgroup.
Difficult decisions at the end of life.
Suffering at End of Life: Michigan Status Report & Recommendations Kay Presby MPH RN Pain & Symptom Management Committee
1 Improving Care for the Uninsured by Providing Links to Primary Care Susan H. Busch, Ph.D. 1 Sarah McCue Horwitz, Ph.D. 2 Kathleen M. B. Balestracci,
M. Kay M. Judge, EdD, RN Marjorie J. Wells, PhD, ARNP.
The Challenge of Practice Variations And the Future of Primary Care 2009 Blanchard Memorial Lecture John E. Wennberg May 1, 2009.
Inpatient Palliative Care A hospital service at SOMC where patients can benefit from palliative care consultative services during their hospitalization.
A Cost-Effectiveness Analysis of Maternal Genotyping to Guide Treatment in Postnatal Patients.
Textbook of Palliative Care Communication Section VIII: Opportunities for the Future.
Palliative Care with Older Adults Section 3: Policy Issues Related To Aging And Palliative Care Gunnar Almgren, PhD University of Washington, School of.
Who? What? When? Where? Why? Cecilia L. May, MD October 9, 2015.
Economics of Complementary and Integrative Medicine: Where Do We Go From Here? Patricia M. Herman, ND, PhD, RAND Corporation IM4US Boston August 8, 2014.
A Perspective on Family Medicine and End-of-Life and Palliative Care Peter Selwyn, M.D., M.P.H. Professor and Chairman Department of Family & Social Medicine.
1 A Pay-For-Performance Program for Diabetes Care T.T. Lee, S.H. Cheng* Institute of Health Policy and Management, National Taiwan University, Taiwan,
Longitudinal Evaluation of Physician Payment Reform and Team-Based Care on Chronic Disease Management and Prevention NAPCRG Annual Meeting, October 27,
Tara Kiran1,2, Alex Kopp2, Rick Glazier1,2
Chronic Care Clerkship (CONJ 690)
Skilled Home Health Care: Do Patient’s Benefit?
Payment Reform to Transform Advanced Illness Care
Presentation transcript:

Cost-Effectiveness of Palliative Team Care For Patients Nearing End-Of-Life Society for Medical Decision Making 36 st Annual Meeting – Miami, Florida October , 2014

Contributors Ba’ Pham, PhDRobert Fowler, MD, MSc Peter Tanuseputro, MD, MScDouglas Manuel, MD, MSc Nancy Sikich, MScShamara Baidoobonso, PhD Petros Pechlivanoglou, PhDLes Levin, MD, MSc Murray Krahn, MD, MSc On behalf of the Health Quality Ontario Expert Panel on End-of-Life Care

End-of-Life Care EOL care consumes ~9% of the Ontario healthcare budget Recent policy review for quality improvement Evidence is needed for policy development Support patients according to their wishes and preferences

Objectives To evaluate the cost-effectiveness of in-home palliative team care for EOL patients and their family.

Palliative Team Care Timely identify palliative patients Need assessment Care coordination 24/7 access Symptom, social support interventions Psycho-spiritual care Bereavement care

Methods

Overview Model-based CEA Perspectives Healthcare payer’s (base case) Societal Time horizon: Last year of life Costs in 2014 Canadian dollar

Ontario Palliative Care Decision Model Markov microsimulation model Cycle from 1 to 365 days Cohort of decedents 76 years of age Simulate care transitions Project costs and health outcomes Percentage dying at home Days at home QALY

Model Structure Chronic conditions in LTC home Stable conditions at home Stable conditions at home with HOME CARE

Model Structure Acute illness required inpatient care Acute illness required ER care Chronic conditions in LTC home Stable conditions at home Stable conditions at home with HOME CARE

Model Structure Palliative prognosis required inpatient care Palliative prognosis required acute care in ER Acute illness required inpatient care Acute illness required ER care Chronic conditions in LTC home Palliative prognosis in LTC home Stable conditions at home Palliative prognosis at home with home care Stable conditions at home with HOME CARE

Model Structure Palliative prognosis required inpatient care Palliative prognosis in non-home hospice Palliative prognosis in palliative care ward or ALC Palliative prognosis in complex continuing care Palliative prognosis required acute care in ER Acute illness required inpatient care Acute illness required ER care Chronic conditions in LTC home Palliative prognosis in LTC home Stable conditions at home Palliative prognosis at home with home care Stable conditions at home with HOME CARE

Data Sources Systematic reviews Study with linked health admin data Micro-costing studies In-home Palliative Team Care Unpaid care costs Selected studies reporting health utility Additional literature reviews Systematic Reviews Linked Health Admin. Micro-costing studies Health utility studies

Clinical Evidence Cochrane Systematic Review Gomes et al Health Quality Ontario Systematic Review Sikich et al Systematic Reviews Linked Health Admin. Micro-costing studies Health utility studies

Effects of Palliative Team Care # RCTsOutcomesOutcome Measures Rx versus Ctrl Estimate (95% CI) 4Patient’s QOLEffect size0.25 (0.05, 0.44) 6Hosp. admissionRisk ratio0.81 (0.67, 0.98) 5Hospital days  LOS (-5.24, -0.52) Systematic Reviews Linked Health Admin. Micro-costing studies Health utility studies

Effects of Palliative Team Care # RCTsOutcomesOutcome Measures Rx versus Ctrl Estimate (95% CI) 4Patient’s QOLEffect size0.25 (0.05, 0.44) 6Hosp. admissionRisk ratio0.81 (0.67, 0.98) 5Hospital days  LOS (-5.24, -0.52) 4ER visitRate ratio0.87 (0.70, 1.08) 1ICU admissionRate ratio0.78 (0.53, 1.17) 1ICU days  LOS (0.83, 1.01) Systematic Reviews Linked Health Admin. Micro-costing studies Health utility studies

Ontario Usual Care Study with linked health admin. data at ICES * Cohort of decedents(n=256,284; ) Care received over the previous 12 months Health care costs Home care, long-term, acute and palliative care; Outpatient services; Drugs/devices; Physician, non-physician and laboratory billings Systematic Reviews Linked Health Admin. Micro-costing studies Health utility studies *Ontario Institute for Clinical Evaluative Sciences

Timing of Palliative Care

Transition Rates, e.g., ER Visits

Healthcare Resources Utilization ER: Emergency Room. LTC: Long-Term Care.

Cost of Palliative Team Care Micro-costing study (Klinger et al. 2011) Resource utilization and costs n=95 Ontario EOL patients Systematic Reviews Linked Health Admin. Micro-costing studies Health utility studies

Cost of Palliative Team Care $19 per patient per day Average service duration: 5 months Systematic Reviews Linked Health Admin. Micro-costing studies Health utility studies

Cost of Palliative Team Care

Out-of-Pocket Expenses and Unpaid Care Costs Diary-Based Micro-Costing Study (Coyte et al. 2013) n=119 EOL cancer patients in Toronto Unpaid care costs due to time lost Paid market labor, Household work, Leisure Systematic Reviews Linked Health Admin. Micro-costing studies Health utility studies

Out-of-Pocket Expenses and Unpaid Care Costs

Health Utility Estimates Selected Studies Palliative cancer patients Patients at home (± home care), long-term care Patients in ER, hospital and ICU Systematic Reviews Linked Health Admin. Micro-costing studies Health utility studies

Quality of Life - Patients Palliative Team Care At home (0.78) At home with home care (0.59) ER visit (  =0.01) Hospital stay (  =0.06) ICU stay (  =0.10) * Sources: Van den Hout et al study, including palliative cancer patients

Health Utility – Family A Selected Study Collateral effects on family and caregivers Spillover effects are measurable (Prosser et al. 2014) Standard gamble technique Systematic Reviews Linked Health Admin. Micro-costing studies Health utility studies Estimated Spillover Disutility: ~0.1

Results

Effectiveness Estimates * In-Home Palliative Team Care Usual CarePTCIncr. Dying at home46%51%5% Days at home

Base Case Analysis Notes: PTC In-Home Palliative Team Care. NMB: Net Monetary Benefit at $50,000 per QALY Usual CarePTCIncrementalIncr. NMB Cost 49,96446,788-3,175 4,662 QALY

One-Way Sensitivity Analysis

Daily Cost of Palliative Team Care Threshold : $42 Base: $19 Cost per patient: $4,423 Average service duration: 8 months

Probabilistic Sensitivity Analysis Note: PSA with n= 20,000

Unpaid Care Cost Borne by Family

Quality of Life of Patients and Spillover Effect on Family

Conclusion In-Home Palliative Team Care is likely to be a dominant strategy The associated costs and consequences on the family is uncertain. Additional data are needed to reduce this uncertainty.

Limitations Impact on time to death was not considered QALY framework may not be appropriate for EOL care

Thank you! Comments and Questions?